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We had previously reported that freshly harvested peritoneal macrophages (PM) are in a type I IFN-mediated antiviral
state, which is lost during in vitro culture of PM, concomitantly with a progressive decline in the expression of IFN-b. We
report herein that in vitro culture of PM in the presence of IL-4 or IL-10 results in an enhanced decay of the IFN-b-mediated
antiviral state to vesicular stomatitis virus (VSV). Moreover, IL-4 and IL-10 inhibited the production of type I IFN induced by
LPS or NDV infection, as assessed by IFN production and induction of IFN-mediated antiviral state. The accumulation and
physiological turnover of IFN-b mRNA was not affected by IL-4 or IL-10. Finally, neither IL-10 nor IL-4 exerted any inhibitory
effect on the antiviral activity induced by exogenous type-I IFN. These results suggest that Th2 cytokines, such as IL-4 and
IL-10, act as negative regulators of the type I IFN-mediated antiviral response in PM and may represent stop signals for the






















Macrophages are generally considered important el-
ements in natural resistance against infections (Mo-
gensen and Virelizier, 1987; Murray, 1992). These cells
are intimately related to the interferon (IFN) system and
the existence of a so-called “macrophage-interferon alli-
ance” has been postulated (Mogensen and Virelizier,
1987). During viral infections, macrophages are among
the first cells in any organ to be exposed to the intruders
and are generally considered to be the major producers
of type I IFN soon after infection (Mogensen and Vireli-
zier, 1987; Murray, 1992). Several studies performed by
our group over the years have revealed that low levels of
type I IFN (especially IFN-b) are spontaneously ex-
ressed in resting mouse peritoneal macrophages (PM)
nd are responsible for the natural antiviral state of these
ells (Belardelli et al., 1984, 1987; Proietti et al., 1986).
he IFN-b-mediated antiviral state of freshly harvested
acrophages is progressively lost when these cells are
aintained in vitro for a few days. This phenomenon is
ssociated with the rapid loss of IFN-b mRNA accumu-
lation with time in culture (Gessani et al., 1993; Proietti et
al., 1986). This observation led to the hypothesis that
these cells might be exposed in vivo to cytokines/factors
and that their starvation during the in vitro culture could,
in turn, result in the progressive loss of antiviral state. In
this regard, it is of interest that the macrophage antiviral
state can be restored when these cells are exposed in1 To whom reprint requests should be addressed. Fax: (39 06)
9902097. E-mail: gessani@iss.it.
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270vitro to different stimuli, such as LPS, IFN-g or IL-12
(Gessani et al., 1989; Puddu et al., 1997). In particular,
reatment of in vitro cultured PM with LPS or IFN-g
resulted in a marked expression of IFN-b, which restored
heir antiviral state (Gessani et al., 1989).
IL-10 and IL-4 are cytokines endowed with pleiotropic
ffects (Banchereau, 1995; Chomarat and Banchereau,
997; Lalani et al., 1997). Although they were originally
efined as T helper type 2 cytokines produced by acti-
ated Th2 cells as well as basophil/mast cells, it has
ubsequently been demonstrated that IL-10 and IL-4 are
lso secreted by other cell types. In fact, it has been
eported that activated B cells produce IL-4 and IL-10
Banchereau, 1995). In addition, IL-10 is also secreted by
umerous other cell types, including T helper 1 cells and
onocyte/macrophages (Ausiello et al., 1993). Both cy-
okines exhibit a variety of activities on different cell
ypes of the immune system (Banchereau, 1995; Choma-
at and Banchereau, 1997; Lalani et al., 1997). It is well
nown that important macrophage functions are nega-
ively controlled through the activity of IL-4 and IL-10
Bogdan and Nathan, 1993). These effects include the
nhibition of spontaneous and induced production of pro-
nflammatory cytokines (Bogdan et al., 1991; de Waal
alefyt et al., 1991a; Essner et al., 1989; Fiorentino et al.,
1991; Gautam et al., 1992; Hart et al., 1989; Hurme et al.,
1988; Oswald et al., 1992b; Standiford et al., 1990a,
1990b; Takeshida et al., 1996; te Velde et al., 1988, 1990)
and the ability to block macrophage cytotoxic activity
(Nabioullin et al., 1994; Oswald et al., 1992a; Vouldoukis
et al., 1997) and antigen presentation (de Waal Malefyt et
























































271TYPE I IFN REGULATION BY Th2 CYTOKINESon monocyte functions, IL-10 and IL-4 have been shown
to exert an array of immuno-stimulatory effects on B and
T cells (Banchereau, 1995; Bogdan and Nathan, 1993) as
well as on subpopulations of certain murine peritoneal
exudate macrophages (Cao et al., 1989; Crawford et al.,
987; Stuart et al., 1988). With respect to the IFN system,
he inhibitory activity of IL-10 (Fiorentino et al., 1989) and
IL-4 (Lee et al., 1995) on the production of IFN-g has been
eported in T cells. In contrast, little information is cur-
ently available on the effect of IL-4 and IL-10 in the
egulation of type I IFN expression in macrophages.
In the present investigation, we explored the possibil-
ty that type I IFN, either endogenously expressed or
nduced by different stimuli, can be regulated by IL-4 and
L-10. We report that IL-4 and IL-10 down-regulate IFN-b
production at a post-transcriptional level in PM, thus
suggesting that these cytokines can play a role in the
maintenance of macrophages in a “prearmed” state for
immune response to pathogens.
RESULTS
IL-4 and IL-10 accelerate the decay of antiviral state
to VSV in in vitro cultured PM
We have previously demonstrated that the natural an-
tiviral state of PM is strictly linked to a low basal expres-
sion of IFN-b and is progressively lost with time in
ulture (Gessani et al., 1993; Proietti et al., 1986). On the
basis of these observations, experiments were carried
out to evaluate whether IL-4 and IL-10 could affect the
spontaneous IFN-b-mediated antiviral state of PM.
hese cells were thus cultured in the presence or in the
bsence of both cytokines and, at different time points,
heir antiviral state was evaluated by testing the suscep-
ibility to VSV infection. As shown in Fig. 1, the sponta-
eous decay of antiviral state of PM was significantly
ncreased already after 24 h of culture with IL-4 and IL-10
s compared to untreated cultures. A consistently higher
iral replication was still observed after 48 and 72 h of
ulture in the presence of IL-10 and, to a greater extent,
f IL-4 (Fig. 1).
L-4 and IL-10 inhibit the LPS-induced antiviral state
o VSV in in vitro cultured PM
In previous studies (Gessani et al., 1989), we have
demonstrated that LPS induced a potent IFN-b-mediated
antiviral state in PM cultured in vitro for 4 days. There-
ore, experiments were carried out to establish whether
he inhibitory effect of IL-4 and IL-10 observed on the
onstitutive expression of IFN-b was also occurring un-
der conditions in which the expression of IFN-b was
timulated by LPS. As shown in Fig. 2, PM cultured in
itro for 4 days were fully permissive to viral replication.
he addition of LPS to these cultures, 24 h prior to VSV
nfection, strongly inhibited viral replication in these
S
dells. The LPS-induced antiviral state was markedly re-
uced in the presence of IL-4 and IL-10. In contrast,
ulture of PM in the continuous presence of antibody to
L-4 or IL-10 did not enhance the LPS-induced antiviral
tate of PM (Fig. 2). The inhibitory activity of IL-4 and
L-10 on the induction of antiviral state by LPS was
onsistently observed in cells pretreated with IL-4 and
L-10 24 h prior to LPS stimulation (data not shown) or
reated at the same time with LPS and cytokines (Fig. 2).
n contrast, addition of IL-4 and IL-10 2 h after LPS
timulation did not result in any inhibition of the LPS-
nduced antiviral state (data not shown). Experiments
ere carried out to evaluate the optimal dose of IL-4 and
L-10 required to inhibit the LPS-induced antiviral state.
s shown in Fig. 3, IL-4 and IL-10 inhibited the induction
f antiviral state in a dose-dependent manner with max-
mal activity observed at 20–100 ng/ml for IL-10 and 50
g/ml for IL-4, respectively.
L-4 and IL-10 decrease IFN secretion induced
y LPS and NDV
To further characterize the effect of IL-4 and IL-10 on
ype I IFN expression, we investigated the effect of both
ytokines on the secretion of IFN induced in in vitro aged
M by LPS or NDV infection. As shown in Table 1, low
evels of IFN could be detected in LPS-treated PM, in
greement with our previous results (Belardelli et al.,
987). In contrast, no IFN secretion could be detected in
M stimulated with LPS in the presence of IL-4 or IL-10.
FIG. 1. Effect of IL-4 and IL-10 on the spontaneous decay of antiviral
state in PM.PM were harvested from C3H/HeN mice and seeded in 24
well-cluster plates as described in Materials and Methods. PM were
maintained in culture for 3 days in RPMI containing 10% of FCS in the
presence or in the absence of recombinant IL-4 (25 ng/ml) or IL-10 (100
ng/ml). PM were then infected with VSV (0.01 pfu/cell) at different time
points (24, 48 and 72 h). 18 h later, culture supernatants were collected
for virus yields titration. Results are representative of three indepen-
dent experiments.imilar results were obtained in PM stimulated to pro-









272 VARANO ET AL.edly, although not completely, reduced the levels of se-
creted IFN.
We previously reported that IFN-b represents the ma-
jor IFN component (80–85%) induced by LPS treatment or
NDV infection in resting PM (Belardelli et al., 1987).
Neutralization of the NDV-induced antigenic IFN compo-
nents by an excess of monoclonal antibody against ei-
ther IFN-a or IFN-b revealed that both IFN-a and IFN-b
titres, detected in the supernatants of PM infected with
NDV in the presence of IL-4 and IL-10, were decreased to
a comparable extent (i.e., a 3–5-fold reduction; data not
shown) suggesting that the expression of both IFNs was
similarly affected by these cytokines.
IL-4 and IL-10 do not interfere with IFN-b mRNA
ccumulation induced by NDV and LPS
To further characterize the mechanism of action of IL-4
nd IL-10 on the modulation of IFN-b expression, the
ccumulation of IFN-b mRNA was measured after NDV
nfection or LPS treatment of PM. The results of a repre-
entative experiment are shown in Fig. 4. As expected, a
trong induction of IFN-b mRNA expression was de-
tected in control macrophages at early time (4 h) after
infection with NDV (panel A) or LPS treatment (panel B).
The addition of IL-4 and IL-10 at the time of IFN stimu-
lation did not result in any effect on the expression of
virus-induced IFN-b mRNA (panel A). Likewise, the ac-
cumulation of IFN-b transcripts induced by a 4-h treat-
ment with LPS was not significantly affected by IL-4 or
FIG. 2. IL-4 and IL-10 inhibit the LPS-induced antiviral state to VSV in i
o Fig. 1. Some cultures were treated with antibody to IL-4 or IL-10 and m
ells were treated overnight with LPS (1 mg/ml) in the presence or in
cells were infected with VSV and the virus yields titrated as describedIL-10 (panel B). Similar results were obtained at later
times of LPS treatment (8 and 24 h) in the presence ofIL-4 or IL-10 (data not shown). However, some variability
was observed with respect to the effect of IL-10 which
was occasionally (in two out of five experiments) found to
FIG. 3. Dose-dependent inhibition of the LPS-induced antiviral state by
IL-4 and IL-10.PM were harvested and seeded as described in the legend
to Fig. 1. At Day 4 of culture, cells were treated overnight with LPS (1 mg/ml)
in the presence or in the absence of different doses of IL-4 (50, 10, 2 ng/ml)
ultured PM.PM were harvested and seeded as described in the legend
ed in the continuous presence until LPS stimulation. At Day 4 of culture,
ence of IL-4 (25 ng/ml) or IL-10 (100 ng/ml). At the end of incubation,
legend to Fig. 1.n vitro cor IL-10 (100, 20, 4 ng/ml). At the end of incubation, cells were infected with











































273TYPE I IFN REGULATION BY Th2 CYTOKINESbe capable of inhibiting IFN-b mRNA accumulation (data
ot shown).
L-4 and IL-10 do not affect the biological activity
f exogenous type I IFN
We then carried out a series of experiments aimed at
valuating the effect of IL-4 and IL-10 on the biological
ctivity of exogenous type I IFN. In vitro cultured PM
ere treated with type I IFN under different experimental
onditions (continuous presence, 24 h of pre-treatment
TABLE 1
IL-4 and IL-10 Inhibit the Production of IFN Induced






None 1,664 6 244 24 6 8
IL-10 580 6 68 #4
IL-4 416 6 60 #4
Note. PM were harvested and seeded as described in the legend to
Fig. 1. At day 4, cells were stimulated to produce IFN by LPS treatment
(1 mg/ml) or NDV infection (640 HAU/well) in the presence or in the
bsence of IL-4 (25 ng/ml) or IL-10 (100 ng/ml). Culture supernatants
ere collected for IFN titration 24 h later. Biological activity of IFN was
easured on L929 cells as described in Materials and Methods.
FIG. 4. Effect of IL-4 and IL-10 on the accumulation of IFN-b mRNA
nduced by LPS or NDV infection.PM were harvested from C3H/HeN
ice and seeded in 10 cm-diameter petri dishes (6 3 106 cells/dish). At
ay 3 of culture, PM were infected with NDV (panel A; 640 HAU/1 3 106
cells) or treated with LPS (panel B; 1 mg/ml) in the presence or in the
bsence of either IL-4 (25 ng/ml) or IL-10 (100 ng/ml). 4 h later, totala
t
ellular RNA was extracted and analyzed for IFN-b mRNA expression
by RT-PCR.r addition of IL-4 or IL-10 at the same time of IFN). The
esults of a representative experiment are shown in
able 2. The addition of IL-4 and IL-10 to PM completely
ailed to exert any effect on the IFN-induced antiviral
tate under all the experimental conditions tested.
DISCUSSION
Functions of the immune cells, including monocytes/
acrophages, are finely regulated to ensure an ade-
uate response to antigenic stimuli. In this regard, it is
idely recognized that soluble mediators, such as cyto-
ines, play a crucial role in the regulation of the immune
esponse by providing a complex network of interaction
Belardelli, 1995).
Macrophages are generally considered to be impor-
ant elements in natural resistance against viral infec-
ions (Mogensen and Virelizier, 1987; Murray, 1992). Al-
hough nearly all cells are capable of generating an IFN
esponse following viral infections in vitro, macrophages
re considered the most important IFN-producing cells.
oreover, PM produce IFN in vitro when treated with
ndotoxin, polysaccharides and polyanions that are in-
ffective in other cell types (Belardelli et al., 1987; Havell
nd Spitalny, 1983). Notably, mononuclear phagocytes
lay an important role in the immune response to patho-
ens. Because the inflammatory functions of macro-
hages are potentially damaging to normal tissues, a
recise control of their response is provided by anti-
nflammatory cytokines, including IL-4 and IL-10 (Bogdan
TABLE 2
Effect of IL-4 and IL-10 on the Biological Activity of Exogenous
IFN-a/b in in Vitro Cultured PM
Treatments
VSV yield
(mean log10 6 S.E.M.)
Control 4.1 6 0.4
IFN a/b #0.5 6 0.1
IFN a/b 1 IL-10a #0.5 6 0.1
IFN a/b 1 IL-4a 0.6 6 0.2
IFN a/b 1 IL-10b #0.5 6 0.1
IFN a/b 1 IL-4b #0.5 6 0.1
IFN a/b 1 IL-10c #0.5 6 0.1
IFN a/b 1 IL-4c #0.5 6 0.1
Note. PM were harvested and seeded as described in the legend to
Fig. 1. Soon after cell seeding, cultures were either left untreated or
treated with IL-4 (25 ng/ml) or IL-10 (100 ng/ml)a. At day 3, some
culturesb were also treated for 24 h with IL-4 or IL-10. At day 4, 100
U/ml of IFN-a/b was added to culturesa,b whereas some culturesc also
eceived IL-4 and IL-10. All cultures were infected with VSV. After 18 h,
ulture medium was collected for VSV titration.
a Continuous treatment.
b 24-h pretreatment.
c Simultaneous treatment.nd Nathan, 1993). In this regard, it is well established






























































274 VARANO ET AL.tivities of macrophages by down-regulating the produc-
tion of TNF-a, IL-1, IL-6, IL-8, GM-CSF, and G-CSF (Bog-
an et al., 1991; de Waal Malefyt et al., 1991a; Essner et
l., 1989; Fiorentino et al., 1989; Gautam et al., 1992; Hart
et al., 1989; Hurme et al., 1988; Oswald et al., 1992b;
Standiford et al., 1990a, 1990b; Takeshida et al., 1996; te
elde et al., 1988, 1990).
In this study, we report that IL-4 and IL-10 act as
egative regulators of IFN-b production by PM. These
ytokines exert their action on the endogenous IFN-b,
onstitutively expressed in freshly harvested PM, as well
s on the production of IFN-b induced by NDV infection
r LPS treatment. Some studies have previously shown
hat IL-10 and IL-4 down-regulate the production of type
IFN induced in human peripheral blood mononuclear
ells (PBMC) by a variety of viral infections (Gobl and
lm, 1992; Payvandi et al., 1998; Zhao et al., 1998). Inter-
estingly, the effect of IL-4 on IFN a/b expression appears
o be dependent on the type of virus used as, in human
BMC, IL-4 inhibits the production of IFN-a induced by
endai virus, but not that stimulated by herpes simplex
irus type I infection (Payvandi et al., 1998). Little infor-
ation was available on the effect of IL-4 and IL-10 on
he regulation of type I IFN expression in monocytes/
acrophages. In this regard, a previous study by Nicko-
aus and colleagues (Nickolaus and Zawatzky, 1991)
howed that IL-4 inhibits IFN-b synthesis observed in
-CSF cultured mouse bone marrow-derived macro-
hages. Recently, it has also been reported (Tebo et al.,
998) that IL-10 suppresses the IP-10 gene transcription
y inhibiting the production of type I IFN in murine elic-
ted PM.
We report herein that IL-4 and IL-10 do not affect the
ccumulation of IFN-b mRNA induced by LPS stimulation
r NDV infection. In fact, similar steady-state levels of
hese transcripts were found in the presence or in the
bsence of IL-10 and IL-4, thus indicating that both cy-
okines exert their action at a post-transcriptional level.
n previous studies, the inhibitory effect of IL-4 and IL-10
n type I IFN production in human PBMC (Gobl and Alm,
992; Payvandi et al., 1998; Zhao et al., 1998) or mouse
one marrow-derived macrophages (Nickolaus and Za-
atzky, 1991) was shown to be mediated by a reduction
n type I IFN transcripts accumulation. The apparent
iscrepancy between our results and those reported by
thers (Gobl and Alm, 1992; Nickolaus and Zawatzky,
991; Payvandi et al., 1998; Zhao et al., 1998) may be, at
east in part, explained by differences in the cell types
sed (PBMC or bone marrow-derived macrophages ver-
us PM). In the majority of cell types, the transcription of
FN genes is strictly controlled and their expression is
enerally triggered after an appropriate stimulation (Kal-
akolanu and Borden, 1996). Notably, PM apparently reg-
late both type I and type II IFN genes by means of
dditional and unique mechanisms, since these genes
re constitutively expressed under physiological condi-ions (Belardelli et al., 1984, 1987; Gessani et al., 1993).
hus, murine PM represents a unique system for study-
ng the expression and regulation of IFN genes. Further-
ore, PM appear to up-modulate the expression of IFN-b
gene in response to different stimuli by various mecha-
nisms depending on the type of inducer. In this regard,
we have previously demonstrated that viral infection
(NDV) results in a transcriptional activation of IFN-b gene
expression, whereas LPS and IFN-g enhances the accu-
mulation of IFN-b mRNA by affecting its turnover (Ges-
sani et al., 1991).
In this study, we also investigated whether IL-4 and
IL-10 could affect the biological activity of type I IFN in
PM. We report that the antiviral state induced by type I
IFN in cultured PM is not affected by IL-4 and IL-10. In
this regard, Lohoff and colleagues (Lohoff et al., 1990)
previously reported that IL-4 antagonizes the antiviral
activity exerted by both type I and type II IFNs in murine
L929 fibroblast cells. Cell type–specific differences in the
development of an IFN-mediated antiviral state could
provide an explanation for the different effect of IL-4
observed in primary PM versus that detectable in an
established fibroblast cell line.
The stimuli responsible for the maintenance of the
constitutive expression of IFN-b have not yet been fully
lucidated. It is reasonable to assume that low levels of
ndotoxin and/or cytokines (IFN-g and IL-12) released in
he peritoneal microenvironment by various cell types
an play a role in this phenomenon. In consideration of
he importance of type I IFN expression for the antiviral
unctions exerted by PM, it is reasonable to assume that
his production needs to be regulated. We suggest that
L-4 and IL-10 can play a role in the regulation of IFN-b
expression in PM. These cells can be considered in a
physiological “prearmed” state for immune response to
pathogens. IFN-b and IFN-g, constitutively expressed at
very low levels, can be rapidly up-modulated in response
to viral infection, either directly or indirectly through the
action of early produced cytokines (IL-12). In this sce-
nario, IL-4 and IL-10 could represent stop signals for IFN
production, interfering in this process by post-transcrip-
tional mechanisms. The finding that IFN-b transcripts are
not affected by the presence of these Th2 cytokines
would allow these cells to promptly respond to a further
stimulation, when the concentration of IL-4 and IL-10
decreases at biologically inactive levels.
MATERIALS AND METHODS
Mice
Male C3H/HeN (5 week old) were obtained from
Charles River, Italia S.p.A. (Milan, Italy). Mice were kept















275TYPE I IFN REGULATION BY Th2 CYTOKINESPeritoneal macrophage cultures
Resting PM were harvested by washing the peritoneal
cavity with RPMI 1640 medium containing 10% heat-
inactivated fetal calf serum (FCS) and seeded in 24
well-cluster plates (1 3 106 cells/well). After 1 h, non-
adherent cells were removed by washing three times
with medium. PM were then maintained in culture for 4
days in RPMI 1640 containing 10% FCS. Experiments
were undertaken when the cells were firmly adherent to
the culture wells after vigorous washing. Over 95% of the
cells stained for nonspecific esterase and were positive
in immunofluorescence studies with monoclonal anti-
body (F4/80) specific for mouse macrophages, as previ-
ously described (Puddu et al., 1997).
Reagents
Recombinant murine IL-4 was purchased from Gen-
zyme (Cambridge, MA) whereas recombinant mouse
IL-10 was purchased from PharMingen (San Diego, CA).
RPMI 1640 medium (M.A. Bioproducts, Walkersville, MD)
was supplemented with penicillin (100 u/ml), streptomy-
cin (100 mg/ml), L-glutamine (2mM), and 10% heat-inac-
ivated FCS. All tissue culture reagents were purchased
s endotoxin-free lots, as assessed by the Limulus ame-
bocyte assay. LPS from Escherichia Coli (serotype
026B6) was purchased from Sigma (Saint Louis, MI).
Mouse IFNa/b (2 3 107 U/mg protein) was produced in
C243–3 murine cells by a modification of the method
previously described by Tovey and colleagues (Tovey et
al., 1974). Briefly, confluent cells were primed by the
addition of 10 units/ml of IFN in modified MEM medium
containing 10% FCS and 1 mM sodium butyrrate. After
16 h at 37°C, cells were infected with NDV at the multi-
plicity of infection of 1 in MEM containing 0.5% FCS and
5 mM teofylline. Eighteen hours later, culture superna-
tants were collected and centrifuged at 1500 rpm for 10
min. IFN was concentrated and partially purified by am-
monium sulfate precipitations and dialysis against dis-
tilled water and PBS.
Infection of PM with vesicular stomatitis virus (VSV)
and titration of virus yields
PM were infected with VSV as reported in detail else-
where (Belardelli et al., 1987). Virus yields were titrated
on monolayers of mouse L929 cells as previously de-
scribed (Belardelli et al., 1987).
Induction and assay of IFN
PM were seeded in 24 well-cluster plates at the cell
density of 1 3 106 in 1 ml of RPMI 1640 medium con-
taining 10% heat-inactivated FCS. Cells were then in-
fected with Newcastle Disease virus [NDV, 640 hemoag-
p
Gglutination units (HAU) per 1 3 106 cells] or incubated
with 1 mg/ml of LPS. After 1 h of incubation at 37°C (NDV)
or 1 h at 25°C followed by a further hour at 37°C (LPS)
cells were washed and incubated for 18 h in fresh me-
dium at 37°C. The IFN secreted was measured by the
cytophatic effect inhibition assay in mouse L929 cells
infected with VSV (Belardelli et al., 1987). The IFN con-
centration is expressed in reference units/ml by compar-
ison with standards obtained from the National Institutes
of Health. Analysis of antigenic components of IFNs
produced by PM after induction with NDV or LPS was
carried out by determining IFN titres in the presence of
an excess amount of monoclonal antibody to either
IFN-a or IFN-b. The origin of hybridomas producing rat
anti-MuIFN-a (clone 4E-A1) and anti-MuIFN-b (clone 7F-
D3) monoclonal antibodies has been described else-
where (Kawade and Watanabe, 1987).
RT-PCR of IFN-b mRNA
Total cellular RNA, prepared by the method of Chirg-
win et al., (1979), was reverse transcribed in a 20 ml
reaction containing 0.5 mg of total RNA, 0.1 mg oligo-dT
(12–18 mer; Pharmacia, Uppsala, Sweden), 50 U Moloney
murine leukemia virus reverse transcriptase (Gibco BRL),
0.5 mM each of dATP, dCTP, dGTP, dTTP, 10 mM DTT, 50
mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2. After
incubation at 37°C for 1 h, 3 ml of the cDNA product were
amplified in a 20 ml reaction containing 10 mM Tris-HCl
(pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001% (wt/v) gelatin,
.2 mM each of dATP, dCTP, dGTP and dTTP, 100 ng of
32P-labeled sense primer and the same amount of unla-
eled antisense primer and 0.5 U of Taq polymerase
(Perkin–Elmer Cetus, Norwalk, CT) by using a PTC-100
DNA Thermal Cycler (M.J. Research, Watertown, MA).
The amplification program consisted of an initial dena-
turation of 3 min at 95°C followed by 30 repeated cycles
of denaturation for 40 s at 90°C, primer annealing for
40 s at 62°C and extension for 60 s at 72°C. The PCR
products were separated on 5% polyacrilamide gel. A
negative control lacking template RNA or RT was in-
cluded in each experiment. Amplifications at several RT
product dilutions have been carried out with mRNA used
as internal controls (b-actin and GAPDH) as previously
eported (Ausiello et al., 1993). The outcome of amplifi-
ation products is linearly related to the RNA concentra-
ion allowing a semiquantitative determination of its con-
ents. By using these experimental conditions, overlap-
ing results on the quantification of specific mRNA have
een obtained by Rnase protection assay as previously
escribed (Ausiello et al., 1993; Fantuzzi et al., 1999).
The sequences for the primers used are as follows:
APDH sense primer CCATGGAGAAGGCTGGGG; anti-
ense primer CAAAGTTGTCATGGATGACC; IFN-b sense
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